Fit-for-purpose biomarker method validation in anticancer drug development
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference76 articles.
1. Medicine. The NIH roadmap;Zerhouni;Science,2003
2. Effective incorporation of biomarkers into phase II trials;McShane;Clin. Cancer Res.,2009
3. Can the pharmaceutical industry reduce attrition rates?;Kola;Nat. Rev. Drug Discov.,2004
4. From darkness to light with biomarkers in early clinical trials of cancer drugs;Carden;Clin. Pharmacol. Ther.,2009
5. Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs;Wagner;Clin. Pharmacol. Ther.,2007
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Magnetic solid phase extraction followed by in-situ derivatization with core–shell structured magnetic graphene oxide nanocomposite for the accurate quantification of free testosterone and free androstenedione in human serum;Journal of Chromatography B;2022-04
2. Evaluation of liver tissue extraction protocol for untargeted metabolomics analysis by ultra‐high‐performance liquid chromatography/tandem mass spectrometry;Journal of Separation Science;2021-08-20
3. Development of Novel, Value-Based, Digital Endpoints for Clinical Trials: A Structured Approach Toward Fit-for-Purpose Validation;PHARMACOL REV;2020
4. Development of Novel, Value-Based, Digital Endpoints for Clinical Trials: A Structured Approach Toward Fit-for-Purpose Validation;Pharmacological Reviews;2020-09-21
5. Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges;Cancers;2020-01-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3